Amgen Inc. (AMGN)

• Annual Data
• Quarterly Data

Amgen Inc., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders’ Equity (quarterly data)

Based on: 10-Q (filing date: 2018-10-31), 10-Q (filing date: 2018-07-27), 10-Q (filing date: 2018-04-25), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-26), 10-Q (filing date: 2017-07-26), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-14), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-29), 10-Q (filing date: 2016-05-02), 10-K (filing date: 2016-02-16), 10-Q (filing date: 2015-11-02), 10-Q (filing date: 2015-08-05), 10-Q (filing date: 2015-04-27), 10-K (filing date: 2015-02-19), 10-Q (filing date: 2014-10-29), 10-Q (filing date: 2014-08-05), 10-Q (filing date: 2014-04-30), 10-K (filing date: 2014-02-24), 10-Q (filing date: 2013-10-29), 10-Q (filing date: 2013-08-06), 10-Q (filing date: 2013-05-03).

Item	Description	The company
Current liabilities	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.	Amgen Inc.’s current liabilities as a percentage of total liabilities and stockholders’ equity increased from Q1 2018 to Q2 2018 and from Q2 2018 to Q3 2018.
Noncurrent liabilities	Amount of obligation due after one year or beyond the normal operating cycle, if longer.	Amgen Inc.’s noncurrent liabilities as a percentage of total liabilities and stockholders’ equity declined from Q1 2018 to Q2 2018 and from Q2 2018 to Q3 2018.
Total liabilities	Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.	Amgen Inc.’s total liabilities as a percentage of total liabilities and stockholders’ equity declined from Q1 2018 to Q2 2018 but then increased from Q2 2018 to Q3 2018 exceeding Q1 2018 level.
Stockholders’ equity	Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.	Amgen Inc.’s stockholders’ equity as a percentage of total liabilities and stockholders’ equity increased from Q1 2018 to Q2 2018 but then declined significantly from Q2 2018 to Q3 2018.